Alivus Life Sciences Key Metrics

BSE: 543322 | NSE: ALIVUS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs
1,116.65 +13.85 (1.26%)Updated : 23 May 2025
Ratios
Return on average equity - 5 year average24.68
Net Income/employee - trailing 12 month0.00
Revenue/employee - most recent fiscal year0.00
Return on investment - most recent fiscal year18.14
Return on average assets - most recent fiscal year15.51
Receivables turnover - most recent fiscal year2.75
Return on investment - trailing 12 month18.14
Return on average assets - trailing 12 month15.51
Inventory turnover - most recent fiscal year1.60
Inventory turnover - trailing 12 month1.61
Revenue/employee - trailing 12 month0.00
Return on average assets - 5 year average17.43
Net Income/employee - most recent fiscal year0.00
Return on average equity - trailing 12 month18.86
Receivables turnover - trailing 12 month2.75
Asset turnover - most recent fiscal year0.76
Asset turnover - trailing 12 month0.76
Return on average equity - most recent fiscal year18.86
Return on investment - 5 year average23.95
Recommended For You
Trending Stocks
436.30+10.20(2.39%)
2,413.50+50.65(2.14%)